![]() |
市场调查报告书
商品编码
1754009
2025 年至 2033 年光声影像市场报告(按产品、适应症、应用、最终用途和地区)Photoacoustic Imaging Market Report by Product, Indication, Application, End Use, and Region 2025-2033 |
2024年,全球光声成像市场规模达到1.09亿美元。展望未来, IMARC Group预计到2033年,该市场规模将达到3.17亿美元,2025-2033年期间的复合年增长率(CAGR)为12.6%。市场成长主要得益于混合成像技术的不断进步、光声成像在肿瘤学中用于高分辨率肿瘤可视化的广泛应用,以及为提高诊断准确性和探索新的临床应用而不断增加的研发投入。
光声成像,也称为光声成像,是一种非侵入性生物医学成像技术,无需使用电离辐射即可捕捉生物组织影像。它是一种基于光声效应的混合成像模式,将吸收的光能转换为声能。与传统成像技术相比,它具有许多优势,包括高穿透力、高深度和高影像分辨率,无有害电离辐射,以及在成像深度上进行分子靶向。它可用于检测生理特性和天然存在的髮色团,例如脂质、黑色素、血红蛋白浓度以及水和氧饱和度。此外,它还广泛用于肿瘤定位、脑功能、皮肤黑色素瘤检测以及高铁血红蛋白测量。因此,光声成像在全球范围内正获得巨大的发展。
成像系统的持续技术进步
光声成像市场需求随着成像技术的不断发展而显着增长。更先进的混合成像系统透过将光声成像与光学和超音波方法相结合,提供更佳的功能成像和更高的解析度。这些发展使得即时可视化生物组织成为可能,并具有更好的深度穿透力和对比度,尤其适用于肿瘤学和心血管应用。透过先进的软体和演算法实现影像重建和解读的改进正受到大众的青睐。最近的一项研究介绍了一种使用基于硅光子学的LDV的非接触式光声方法,其性能优于商用系统,并能重建精确的二维影像。这些技术创新使系统更加通用,推动了其在科研和临床领域的应用,并支持了整体市场的成长。
肿瘤学领域的应用日益广泛
这些影像解决方案在肿瘤学领域的应用日益广泛,也促进了光声成像市场的成长。该技术能够提供肿瘤血管和组织氧合水平的高解析度影像,这对于早期癌症检测、追踪治疗反应和指导手术具有重要意义。对于需要反覆扫描的患者,非侵入式光声影像比CT和MRI等传统影像方式更安全。随着全球癌症发生率的上升,更精确的即时诊断仪器正变得越来越受欢迎。
增加研发投入
由于研发支出不断成长,市场扩张速度加快,光声成像市场占有率也随之扩大。为了改善患者预后和诊断准确性,企业和研究机构正致力于开发影像系统并探索新的临床应用。快速开发新型造影剂以增强某些组织和疾病的影像效果是这些努力的另一个目标。除了核心技术的进步外,政府资金以及产学研战略合作也进一步支持了该领域的持续创新。因此,研发工作正在拓宽光声成像的潜在用途,推动各种医疗和研究领域的需求,并增强光声成像市场分析。
The global photoacoustic imaging market size reached USD 109 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 317 Million by 2033, exhibiting a growth rate (CAGR) of 12.6% during 2025-2033. The market growth is primarily driven by the ongoing advancements in hybrid imaging technologies, the expanding use of photoacoustic imaging in oncology for high-resolution tumor visualization, and rising investments in research and development to improve diagnostic accuracy and explore new clinical applications.
Photoacoustic imaging, also known as optoacoustic imaging, is a non-invasive biomedical imaging technique that captures images of biological tissues without using ionizing radiation. It is a hybrid modality that functions on the photoacoustic effect, wherein absorbed optical energy is converted into acoustic energy. It offers various advantages over conventional imaging techniques, including high penetration, depth, and image resolution, no harmful ionizing radiation, and molecular targeting at imaging depth. It is employed in detecting physiological properties and naturally occurring chromophores, such as lipids, melanin, hemoglobin concentration, and water and oxygen saturation. Besides this, it is extensively used for tumor mapping, functioning of the brain, detecting skin melanoma, and measuring methemoglobin. As a result, photoacoustic imaging is gaining immense traction across the globe.
Continual Technological Advancements in Imaging Systems
According to the photoacoustic imaging market, the demand is increasing significantly due to ongoing developments in imaging technology. More advanced hybrid imaging systems are offering improved functional imaging and higher resolution through the combination of photoacoustic imaging with optical and ultrasonic approaches. These developments render it possible to visualize biological tissues in real time with better depth penetration and contrast, especially for oncology and cardiovascular applications. Improved image reconstruction and interpretation through advanced software and algorithms are being preferred by the masses. A recent study introduced a non-contact photoacoustic method using a silicon photonics based LDV, which outperformed commercial systems and reconstructed accurate 2D images. These technological innovations are making the systems more versatile, driving their adoption in both research and clinical settings, and supporting the overall market growth.
Growing Application in Oncology
The increasing application of these imaging solutions in oncology is also contributing to the photoacoustic imaging market growth. Its ability to provide high-resolution images of tumor vasculature and tissue oxygenation levels renders the technique invaluable for early cancer detection, tracking treatment response, and guiding surgery. For patients who need repeated scans, non-invasive photoacoustic imaging is a safer option than conventional imaging modalities such as CT and MRI. More precise, real-time diagnostic instruments are becoming increasingly popular as the prevalence of cancer rises worldwide.
Increasing Research and Development Investments
The market is expanding more quickly as a result of the growing research and development (R&D) expenditures, thereby augmenting the photoacoustic imaging market share. In order to improve patient outcomes and diagnostic accuracy, businesses and research institutes are concentrating on developing imaging systems and investigating novel clinical applications. The rapid development of novel contrast agents enhancing the imaging of certain tissues and disorders is another goal of these efforts. In addition to the advancement of core technologies, ongoing innovation in this field is also being further supported by government financing and strategic collaborations between industry and academics. Consequently, research and development endeavors are broadening the possible uses of photoacoustic imaging, propelling demand in diverse medical and research domains, and augmenting photoacoustic imaging market analysis.